Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods

Histrap ff 1 ml column

Manufactured by GE Healthcare
Sourced in Sweden, United States, Germany, United Kingdom
About the product

The HisTrap FF 1 mL column is a pre-packed, affinity chromatography column designed for the purification of histidine-tagged recombinant proteins. The column contains Ni Sepharose High Performance resin, which has a high binding capacity for histidine-tagged proteins. The column can be used with a variety of buffers and is compatible with common protein purification workflows.

Automatically generated - may contain errors

Market Availability & Pricing

Is this product still available?

Get pricing insights and sourcing options

The spelling variants listed below correspond to different ways the product may be referred to in scientific literature.
These variants have been automatically detected by our extraction engine, which groups similar formulations based on semantic similarity.

Product FAQ

34 protocols using «histrap ff 1 ml column»

1

Purification of Recombinant E. coli BL21 Enzyme

2025
Recombinant E. coli BL21 was inoculated into 50 mL TB media with 50 µg/mL kanamycin, cultured at 37 °C and 200 rpm for 2 h. Subsequently, 0.5 mM IPTG was added to the medium. After 12 h at 22 °C and 200 rpm, cells were harvested by centrifugation and washed three times with phosphate buffer (pH 7.4). The cells were ultrasonically broken and centrifuged at 12,000 × g and 4 °C for 20 min to obtain the crude enzyme solution. The cells were broken in an ice-water bath using an ultrasonic cell crusher at 200 W power for 1s and 2s off, for a total working time of 15 min. Protein purification was achieved using HisTrap™ FF 1 mL column (GE Healthcare) [37 (link)]. The purification protocol involved loading the sample with phosphate buffer (pH 7.4, 20 mM imidazole) for 10 min, washing nonspecific proteins with phosphate buffer (pH 7.4, 100 mM imidazole) for 10 min, and eluting the target protein phosphate buffer (pH 7.4, 200 mM imidazole) for 5 min. Protein was analyzed by SDS polyacrylamide gel electrophoresis (SDS-PAGE) using a 12% polyacrylamide gel. TB medium was composed of peptone (12 g/L), yeast extract (24 g/L), K2HPO4•3H2O (12.55 g/L), KH2PO4 (2 g/L), and glycerol (10 g/L). The protein concentration was determined by the method of Bradford (Bio-Rad, Richmond, CA, USA) with bovine serum albumin as standard [38 (link)].
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Purification of pBI-IpaDSTxB Protein

2024
Puri cation of pBI-IpaDSTxB protein was carried out by utilizing a HisTrap FF 1mL column (GE Healthcare, Sweden) and Amicon Ultra-4 10K centrifugal lter device (Merck Millipore). For the puri cation of other four constructs, the method described by (Sarvestani et al. 2021 (link)) was used in quadruplicate.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Purification of pBI-IpaDSTxB Protein

2024
Puri cation of pBI-IpaDSTxB protein was carried out by utilizing a HisTrap FF 1mL column (GE Healthcare, Sweden) and Amicon Ultra-4 10K centrifugal lter device (Merck Millipore). For the puri cation of other four constructs, the method described by (Sarvestani et al. 2021 (link)) was used in quadruplicate.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Purification of His-tagged Proteins from E. coli

2023
Transformed E. coli strains were grown to an OD600 of 0.5 in LB medium containing the appropriate antibiotics at 37 °C and 250 rpm. IPTG at a final concentration of 0.1 mM was added, and the cultures were incubated overnight to induce protein production at 12 °C and 250 rpm. Cells were harvested using centrifugation at 11,000 rpm and 4 °C for 15 min, and the resulting pellets were resuspended in 30 mL of BugBuster Protein Extraction Reagent containing Benzonase Nuclease (Merc Millipore, Darmstadt, Germany). After incubation at 4 °C for 30 min, centrifugation at 11,000× g and 4 °C for 20 min was performed to remove cell debris. The supernatant was filtered through 45 µm syringe filters (Whatman, GE Healthcare Life Sciences, Pittsburgh, PA, USA) and applied to a 1 mL HisTrap FF column (GE Healthcare Life Sciences, Pittsburgh, PA, USA) at a flow rate of 1.0 mL min−1. The bound proteins were eluted with 20 mM HEPES, 400 mM imidazole, and 400 mM NaCl (pH 7.5) after washing with 20 mM HEPES, 20 mM imidazole, and 400 mM NaCl (pH 7.5). Fractions corresponding to the absorbance peak at 280 nm were collected and verified using SDS-PAGE and then pooled and desalted with 20 mM HEPES (pH 7.0) using an Amicon Ultra 15 mL Filter (Merck Millipore, Darmstadt, Germany) with an MW cutoff of 10 kDa. All purification steps were performed at 4 °C. Protein concentrations were determined using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA).
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Recombinant Protein Expression and Purification

Expression and purification of recombinant proteins was performed as described in Ahmadi et al. (2020) (link). Briefly, proteins were expressed in E. coli BL21(DE3) using autoinduction media for approximately 18h at 30°C. Cells were harvested by centrifugation (10,000 × g, 30 min, 4°C), resuspended in ice cold 30 mM Tris–HCl pH 8.0, 1 mM EDTA, 20% sucrose (w/v), incubated on ice, and pelleted as before. Pellets were dissolved in ice cold 5 mM MgSO4, incubated on ice, and pelleted. Both buffers were supplemented with 25 U/mL Benzonase Nuclease (Millipore), cOmplete Protease Inhibitor Cocktail (Roche) and 1.5 kU/mL r-lysozyme (Sigma Aldrich). Supernatants were loaded onto a HisTrap FF 1 mL column (GE Life Sciences) connected to an ÄKTA prime plus system (GE Healthcare), and the proteins were eluted using increasing concentrations of imidazole in PBS. Proteins were concentrated and buffer exchanged to PBS using Pierce Protein Concentrator PES, 3K MWCO, centrifugal concentrators, and concentrations were determined at 280 nm, assuming 1 absorbance unit is equivalent to 1 mg/mL of protein.
For the ex vivo characterization experiments, test material of untagged BL1.1 and BL1.2 constructs were produced at Novozymes laboratories, Bagsværd, Denmark. The test product was produced via microbial fermentation with secretory expression, after which the biomass was filtered, and the final test article was delivered as a frozen supernatant containing the protein product for the challenge trial. The test material was confirmed for binding activity before it was used for the trial.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

Top 5 protocols citing «histrap ff 1 ml column»

1

Purification and Antibody Production of CdnL

His6-SUMO-CdnL was overproduced in Rosetta (DE3) pLysS E.coli cells from pEG1129 by inducing for 3 hr at 30 oC with 0.5 mM IPTG at OD600 of 0.5. Cells were harvested by centrifugation, resuspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 300 mM KCl, 20 mM imidazole, and 10% glycerol), lysed with 1 mg/mL lysozyme, sonicated and centrifuged at 4 oC for 30 min at 15000 x g. Supernatant was loaded onto a HisTrap FF 1 mL column (GE Life Sciences) and eluted with lysis buffer with 300 mM imidazole, cleaved with His6-Ulp1 (SUMO protease) at 1:500 (protease: fusion) molar ratio overnight while dialyzing into lysis buffer. Sample was reloaded onto HisTrap FF 1mL and flow through was collected to separate His6-SUMO and His6-Ulp1 from CdnL. CdnL fraction was dialyzed into PBS prior to antibody production.
Cells in log phase were isolated and lysed in SDS-PAGE loading buffer by boiling for 5 min. Standard procedures were used for SDS-PAGE and transfer to nitrocellulose membrane. CdnL antisera was generated by immunizing a rabbit with CdnL purified as above (Pocono Rabbit Farm & Laboratory). Specificity was determined using cell lysates with deleted or overexpressed cdnL. CdnL antisera was used at 1:5000.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
2

Purification of Recombinant Antibody Fragments

The TPL0027_01_F7 scFv clone was inoculated into 2xYT medium supplemented with 2% (w/v) glucose and 50 μg/mL kanamycin (2xYT-GK) and incubated O/N at 250 rpm, 30 °C. 500 mL auto-induction medium was inoculated using the O/N cultures and incubated O/N at 30 °C, 200 rpm. The cultured cells were centrifuged at 4,300 × g for 10 min, supernatant was discarded, and the pellet was re-suspended in 50 mL TES-buffer (30 mM Tris–HCl pH 8.0, 1 mM EDTA, 20% sucrose (w/ v)) containing 25 U/mL Benzonase Nuclease (Millipore, E1014-25KU), 2 μL/mL 25x cOmplete Protease Inhibitor Cocktail (Roche, 11836145001) and 1.5 kU/mL r-lysozyme (~ 70,000 U/mg, Sigma Aldrich, 62971-10G-F). After 20 min of incubation on ice, the cells were centrifuged at 4,300×g for 10 min, supernatant was decanted, and the cell pellet kept on ice. The cell pellet was re-suspended in 50 mL of 5 mM MgSO4 supplemented with similar amounts of Benzonase Nuclease and r-lysozyme as above, 40 μL/mL cOmplete Protease Inhibitor Cocktail, and incubated on ice for 20 min. After centrifugation at 4,300×g for 10 min, supernatant was pooled with the supernatant from the previous step and kept on ice. The pooled supernatants were centrifuged once again at 30,000×g for 30 min. Purification of His-tagged scFvs was performed using HisTrap FF 1 mL columns (GE Life Sciences, 17531901), which later were loaded on to an ÄKTAprime plus system (GE Healthcare) in order to elute the scFvs from the columns. Protein concentration was determined at 240 nm, assuming 1 absorbance unit is equivalent to 1 mg/mL of protein.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
3

Purification of BLM Mutant Variants

The BLM(S666A) and BLM(S729A) variants were generated from pJK1-BLM(WT) by a site-directed mutagenesis strategy. The resulting pJK1- BLM(S666A) and pJK1-BLM(S729A) were transformed in Saccharomyces cerevisiae-strain JEL1. Cell growth, protein induction and purification were performed as described in (7 (link)) with the exception that the nickel affinity chromatography was performed using a HisTrap FF 1-ml column (GE Healthcare) according to the manufacturer′s recommendations. Eluted proteins were dialyzed overnight against the storage buffer (50-mM Hepes pH7.5, 1-mM DTT, 0.1-mM EDTA, 200-M NaCl, 10% glycerol). The concentration of the different purified BLM variants was determined by Coomassie Blue staining using bovine serum albumin (BSA) as a standard.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
4

Engineered Receptor-Simulating Protein Purification

The gene for toxin-simulating protein (TSP) was designed to include beta-galactosidase from E. coli BL21 on its N-terminus (gene bank code CAQ30819) and the receptor binding domain of BoNT/A, also designated HC fragment, on its C-terminus (gene bank code M30196, amino acids 872-1296). The two proteins were connected by a flexible linker with the sequence (GGGGS)3 and a His6 tag was added to the C-terminus. The receptor-simulating protein (RSP) gene consists of a GST tag on its N-terminus and the fourth luminal domain of Mus musculus SV2C (amino acids 545–580, GenBank code AAI37862.1) on its C-terminus. Synthetic genes with optimized codon usage were prepared by GenScript (Piscataway, NJ, USA) and cloned into pET-9a.
To produce proteins, E. coli BL21(DE3) harboring pET-9a-TSP or pET-9a-RSP was grown in TB media at 18 °C and 250 rpm for ~40 h, and thereafter, the cells were harvested by centrifugation and disrupted by sonication. TSP and RSP were purified using a HisTrap FF 1 mL column and a GSTrap FF 5 mL column (GE Healthcare), respectively, according to the manufacturer’s instructions.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols
5

Purification of His-tagged PhoP Transcription Factor


E. coli BL-21 (DE3) strain carrying pOG-His-PhoP was grown overnight in LB medium containing 50 µg/ml Kan at 37°C with vigorous aeration. The culture was diluted 1∶200 into 300 ml of fresh LB and grown for 2.5 h. To induce expression of the recombinant protein, IPTG was added to 1 mM final concentration, and the culture was grown for an additional 3 h at 30°C and harvested by centrifugation. The pellet was resuspended in 10 ml lysis buffer [50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 1 mM MgCl2 in the presence of DNase I (5 µg/ml) and RNase A (10 µg/ml)]. Cells were disrupted using a French Press (three passages, 1000 PSI) and then centrifuged at 20,000 rpm for 30 min. His6-PhoP was purified from 1 ml of the soluble fraction by a nickel-affinity chromatography using ÄKTApurifier FPLC system (GE Healthcare) and a HisTrap FF 1 ml column (GE Healthcare) at 4°C. The column was washed with 5 ml of washing buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole and 1 mM MgCl2). His6-PhoP was eluted with 5 ml elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole and 1 mM MgCl2) and analyzed on an SDS-polyacrylamide gel. The selected elute fractions were then collected and dialyzed against dialysis buffer [20 mM HEPES (pH 8.0), 100 mM KCl, 20% glycerol, 1 mM DTT and 1 mM MgCl2] on a Sephacryl S-200 gel filtration column. Dialyzed fractions were analyzed by UV absorbance at 280 nm and on an SDS-polyacrylamide gel. The appropriate fractions were pooled and concentrated using a 10 kDa Amicon Ultra centrifugal filter devices (Millipore). Protein samples were stored at −80°C until use.
+ Open protocol
+ Expand Check if the same lab product or an alternative is used in the 5 most similar protocols

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.